你即將離開本站

並前往https://www.pharmtech.com/view/novo-nordisk-acquires-ziylo-potential-800-million-deal-0

Novo Nordisk Acquires Ziylo in Potential $800-Million Deal

Carbometrics has licensed rights to develop non-therapeutic applications of glucose-binding molecules with a focus on developing continuous ...

確定！ 回上一頁

查詢 「carbometrics」的人也找了：

  1. a biomimetic receptor for glucose
    2.
  2. ziylo
    3.
  3. science creates
    4.
  4. anaphite
    5.
  5. bristol startup incubator
    6.
  6. glaia
    7.
  7. unit dy
    8.
  8. imophoron
    9.